UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
2010, ISBN 0309146283, xix, 232
Book
Journal of hepatology, ISSN 0168-8278, 2012, Volume 58, Issue 2, pp. 375 - 384
Gastroenterology and Hepatology | Hepatitis C virus | Host-targeting agents | Antivirals | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Antiviral agents | Viral hepatitis | Infectious diseases | Pharmacology. Drug treatments | Viral diseases | Biological and medical sciences | Medical sciences | Human viral diseases | Antibiotics. Antiinfectious agents. Antiparasitic agents | Antiviral Agents - therapeutic use | Humans | Hepatitis C, Chronic - prevention & control | Hepacivirus - genetics | Genotype | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Enzymes | Care and treatment | Immunodeficiency | Drug resistance | Biological response modifiers | HIV (Viruses) | Prevention | Liver cancer | MicroRNA | Immunotherapy | Transplantation of organs, tissues, etc | Hepatitis C | Health aspects | Index Medicus | Life Sciences | Human health and pathology | Hépatology and Gastroenterology
Journal Article
Journal of internal medicine, ISSN 0954-6820, 05/2018, Volume 283, Issue 5, pp. 500 - 507
intravenous drug use | direct‐acting antiviral agents | elimination | hepatitis C | prevention | policy | direct-acting antiviral agents | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Prevention | Antiviral agents | Control | Hepatitis C | Drug therapy | Hepatitis C virus | Drug abuse | Liver diseases | Complications | Liver | Medical treatment | Risk reduction | Viruses | Patients | Hepatitis | Diagnostic systems | Interferon | Index Medicus
Journal Article
Annals of internal medicine, ISSN 0003-4819, 2012, Volume 157, Issue 11, pp. 817 - 822
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Public health. Hygiene-occupational medicine | Public health. Hygiene | General aspects | Viral hepatitis | Infectious diseases | Prevention and actions | Viral diseases | Biological and medical sciences | Medical sciences | Human viral diseases | Alcohol-Related Disorders - diagnosis | Mass Screening | Antiviral Agents - therapeutic use | Hepatitis C Antibodies - blood | Alcohol-Related Disorders - complications | Humans | Middle Aged | Risk Factors | Aged | Hepatitis C, Chronic - complications | Hepatitis C, Chronic - diagnosis | Hepatitis C, Chronic - drug therapy | Practice guidelines (Medicine) | Hepatitis C | Diagnosis | Hepatitis | Liver diseases | Medical treatment | Clinical trials | Systematic review | Medical screening | Alcohol use | Index Medicus | Abridged Index Medicus
Journal Article
Addiction (Abingdon, England), ISSN 0965-2140, 01/2018, Volume 113, Issue 1, pp. 173 - 182
opioid substitution therapy | mathematical modelling | prescription opioid | needle syringe programmes | Hepatitis C | people who inject drugs | Models, Theoretical | Epidemics | United States - epidemiology | Prevalence | Hepatitis C - drug therapy | Antiviral Agents - therapeutic use | Humans | Substance Abuse, Intravenous - epidemiology | Hepatitis C, Chronic - prevention & control | Male | Hepatitis C, Chronic - drug therapy | Incidence | Substance Abuse, Intravenous - rehabilitation | Indiana - epidemiology | Rural Population | Hepatitis C - epidemiology | Opiate Substitution Treatment - methods | Adult | Female | Hepatitis C, Chronic - epidemiology | Hepatitis C - prevention & control | Needle-Exchange Programs - methods | Prevention | Care and treatment | Analysis | Models | Hepatitis C virus | Health aspects | Epidemiology | Drugs | Intervention | Drug abuse | Treatment needs | Rural communities | Viruses | Infections | Projections | Hepatitis | Reduction | Prevention programs | Human immunodeficiency virus--HIV | Sensitivity analysis | Coverage | Chronic | Disease transmission | Differential equations | Intravenous drug addicts | Scaling | Index Medicus
Journal Article
Annals of internal medicine, ISSN 0003-4819, 01/2016, Volume 164, Issue 2, pp. 84 - 92
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Quality-Adjusted Life Years | United States - epidemiology | Prevalence | Hepatitis C - drug therapy | Antiviral Agents - therapeutic use | Mass Screening - economics | Humans | Disease Progression | Disease Transmission, Infectious - prevention & control | Hepatitis C - diagnosis | Computer Simulation | Cost-Benefit Analysis | Hepatitis C - epidemiology | Hepatitis C - transmission | Prisoners | Prevention | Complications and side effects | Care and treatment | Disease transmission | Research | Diagnosis | Hepatitis C | Disease prevention | Prisons | Hepatitis | Medical screening | Medical treatment | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 03/2019, Volume 393, Issue 10178, pp. 1319 - 1329
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hepacivirus - drug effects | Models, Theoretical | Prevalence | Hepatitis C - drug therapy | Antiviral Agents - therapeutic use | Humans | Mortality | Hepatitis C, Chronic - prevention & control | India - epidemiology | China - epidemiology | Hepatitis C, Chronic - drug therapy | Mass Screening - methods | Incidence | Hepatitis C, Chronic - transmission | Pakistan - epidemiology | World Health Organization - organization & administration | Health Services Accessibility | Hepatitis C - epidemiology | Hepatitis C, Chronic - epidemiology | Hepatitis C - prevention & control | Hepatitis C - transmission | Prevention | Liver cancer | Antiviral agents | Care and treatment | Analysis | Biological response modifiers | Hepatitis C virus | Hepatitis C | Health aspects | Epidemiology | Intervention | Epidemics | Drug abuse | Substance abuse treatment | Demography | Funding | Liver | Viruses | Infections | Blood | Ribavirin | Hepatitis | Reduction | Scaling up | Population | Mathematical models | Diagnosis | Safety | Public health | Sensitivity analysis | Health risks | Risk reduction | Disease control | Screening | Cirrhosis | Fatalities | Scaling | Interferon | Risk management | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Clinical gastroenterology and hepatology, ISSN 1542-3565, 2015, Volume 13, Issue 12, pp. 2140 - 2151
Gastroenterology and Hepatology | Cirrhosis | NAFLD | Surveillance | Hepatitis C | Chemoprevention | Hepatitis B | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Hepatitis B - complications | Liver Neoplasms - prevention & control | Liver Neoplasms - epidemiology | Carcinoma, Hepatocellular - epidemiology | Hepatitis C - drug therapy | Early Detection of Cancer | Carcinoma, Hepatocellular - prevention & control | Humans | Risk Factors | Hepatitis B - drug therapy | Hepatitis C - complications | Prevention | Liver cancer | Algorithms | Analysis | Vaccination | Hepatoma | Hepatitis C virus | Epidemiology | Statins | Index Medicus
Journal Article